rilonacept (IL-1 Trap)
IL1T-AI-0504
Phase 1 small_molecule completed
Quick answer
rilonacept (IL-1 Trap) for Systemic Juvenile Idiopathic Arthritis is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Systemic Juvenile Idiopathic Arthritis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed